Abstract:Abstract Background The ongoing transmission of the Middle East respiratory syndrome coronavirus (MERS-CoV) in the Middle East and its expansion to other regions are raising concerns of a potential pandemic. An in-depth analysis about both population and molecular epidemiology of this pathogen is needed. Methods MERS cases reported globally as of June 2020 were collected mainly from World Health Organization official reports, supplemented by other reliable sources. Determinants for case fatality and spatial diffusion of MERS were assessed with Logistic regressions and Cox proportional hazard models, respectively. Phylogenetic and phylogeographic analyses were performed to examine the evolution and migration history of MERS-CoV. Results A total of 2562 confirmed MERS cases with 150 case clusters were reported with a case fatality rate of 32.7% (95% CI : 30.9‒34.6%). Saudi Arabia accounted for 83.6% of the cases. Age of ≥ 65 years old, underlying conditions and ≥ 5 days delay in diagnosis were independent risk factors for death. However, a history of animal contact was associated with a higher risk (adjusted OR = 2.97, 95% CI : 1.10–7.98) among female cases < 65 years but with a lower risk (adjusted OR = 0.31, 95% CI : 0.18–0.51) among male cases ≥ 65 years old. Diffusion of the disease was fastest from its origin in Saudi Arabia to the east, and was primarily driven by the transportation network. The most recent sub-clade C5.1 (since 2013) was associated with non-synonymous mutations and a higher mortality rate. Phylogeographic analyses pointed to Riyadh of Saudi Arabia and Abu Dhabi of the United Arab Emirates as the hubs for both local and international spread of MERS-CoV. Conclusions MERS-CoV remains primarily locally transmitted in the Middle East, with opportunistic exportation to other continents and a potential of causing transmission clusters of human cases. Animal contact is associated with a higher risk of death, but the association differs by age and sex. Transportation network is the leading driver for the spatial diffusion of the disease. These findings how this pathogen spread are helpful for targeting public health surveillance and interventions to control endemics and to prevent a potential pandemic. Graphical abstract

Epidemiology of Middle East respiratory syndrome and its prevention and control

From SARS to MERS: Evidence and Speculation

Middle East Respiratory Syndrome Coronavirus (Mers-Cov): Challenges in Identifying Its Source and Controlling Its Spread

An overview of the novel coronavirus MERS-CoV

Middle East respiratory syndrome coronavirus and development of vaccines and specific drugs for its control

Middle East Respiratory Syndrome Coronavirus Could be a Priority Pathogen to Cause Public Health Emergency: Noticeable Features and Counteractive Measures

Urgent Development of Effective Therapeutic and Prophylactic Agents to Control the Emerging Threat of Middle East Respiratory Syndrome (MERS)

Middle East Respiratory Syndrome Infection Control and Prevention Guideline for Healthcare Facilities

Epidemiology and evolution of Middle East respiratory syndrome coronavirus, 2012–2020

Molecular Characteristics, Functions, and Related Pathogenicity of MERS-CoV Proteins

A Comparative Analysis of Factors Influencing Two Outbreaks of Middle Eastern Respiratory Syndrome (MERS) in Saudi Arabia and South Korea

Elements of Successful Management of an Imported Middle East Respiratory Syndrome Case in Guangdong, China

Developments in treatment for middle east respiratory syndrome coronavirus (MERS-CoV)

Research progress on human neutralizing monoclonal antibodies against Middle East respiratory syndrome coronavirus

Saudi Arabia's Middle East respiratory syndrome Coronavirus (MERS-CoV) outbreak: consequences, reactions, and takeaways

The transmission dynamics of Middle East Respiratory Syndrome coronavirus

[Small Molecular Agents Against MERS-CoV Infection].

Antibodies And Vaccines Against Middle East Respiratory Syndrome Coronavirus

Risk of global spread of Middle East respiratory syndrome coronavirus (MERS-CoV) via the air transport network

Development of Small-Molecule MERS-CoV Inhibitors.

Assessment of the MERS-CoV epidemic situation in the Middle East region